
Psoriasis and porphyria cutanea tarda, associated with chronic hepatitis C in HIV-infected patients (clinical observation)
Author(s) -
И. А. Коротаева,
И. А. Коротаева,
L. F. Sklyar,
Л. Ф. Скляр,
А. И. Симакова,
А. И. Симакова,
Л. Г. Сингур,
Л. Г. Сингур,
А. Ф. Попов,
А. Ф. Попов
Publication year - 2015
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/0042-4609-2015-91-4-90-94
Subject(s) - porphyria cutanea tarda , polypharmacy , medicine , concomitant , comorbidity , incidence (geometry) , adverse effect , human immunodeficiency virus (hiv) , psoriasis , antiretroviral therapy , dermatology , pediatrics , immunology , viral load , physics , optics
The continued growth of HIV-infected patients is associated on the one hand, with increase of life expectancy because of antiretroviral therapy, and the other - with high incidence of new cases of HIV-infection. It is important to remember that almost every HIV-infected patient has concomitant disease. The presence of comorbidity increases days of hospitalization, disability, impedes rehabilitation and leads to polypharmacy. Moreover, polypharmacy, particularly in HIV-patients, contributes to a sharp increase of adverse local and systemic side effects of drugs. This article presents the clinical examples of skin diseases in patients with HIV-infection.